These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference. December 04, 2024 0 29 Share Added to Email Alerts The guideline on use of sodium-glucose cotransporter–2 (SGLT-2) inhibitors in adults with chronic kidney disease (CKD) was released on...
Tag: <span>SGLT-2 inhibitors</span>
Post
SGLT-2 inhibitors work by inducing a fasting state that triggers metabolic benefits
IMAGE: INVESTIGATOR AT JOSLIN DIABETES CENTER AND ASSOCIATE PROFESSOR AT HARVARD MEDICAL SCHOOL view more CREDIT: JOHN SOARES SGLT-2 inhibitors are a relatively new class of diabetes drugs that have shown many benefits for people with type 2 diabetes who have not responded well to previous interventions, including diet changes and metformin. Patients who take this medication see...